ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RNA Avidity Biosciences Inc

7.96
0.24 (3.11%)
Last Updated: 10:23:38
Delayed by 15 minutes

Period:

Draw Mode:

Volume 278,299
Bid Price 7.96
Ask Price 7.99
News -
Day High 8.07

Low
4.825

52 Week Range

High
25.74

Day Low 7.57
Company Name Stock Ticker Symbol Market Type
Avidity Biosciences Inc RNA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.24 3.11% 7.96 10:23:38
Open Price Low Price High Price Close Price Prev Close
7.78 7.57 8.07 7.72
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,379 278,299 $ 7.83 $ 2,178,859 - 4.825 - 25.74
Last Trade Time Type Quantity Stock Price Currency
10:23:33 50 $ 7.97 USD

Avidity Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
590.59M 74.10M - 9.22M -174M -2.35 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Avidity Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No RNA Message Board. Create One! See More Posts on RNA Message Board See More Message Board Posts

Historical RNA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week7.198.687.197.862,806,5840.7710.71%
1 Month5.808.685.157.122,152,2412.1637.24%
3 Months7.308.684.8256.711,255,8920.669.04%
6 Months11.2812.714.8258.331,074,020-3.32-29.43%
1 Year11.2125.744.82513.891,375,801-3.25-28.99%
3 Years32.5235.874.82515.79683,730-24.56-75.52%
5 Years26.5037.464.82516.46616,835-18.54-69.96%

Avidity Biosciences Description

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease.

Your Recent History

Delayed Upgrade Clock